Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate COVID 19 Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04475107
What this trial is testing

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Who this might be right for
COVID-19
Shin Poong Pharmaceutical Co. Ltd. 113
Post-approval studies (Phase 4)Study completedNCT04709172
What this trial is testing

Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

Who this might be right for
COVID-19 Pneumonia
Meiji Pharma Spain S.A. 20
Testing effectiveness (Phase 2)Study completedNCT05092503
What this trial is testing

JINZHEN for Treatment of Mild to Moderate COVID-19

Who this might be right for
COVID-19
Lianyungang Kanion Group, Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT04337918
What this trial is testing

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection

Who this might be right for
Corona Virus Infection
Sanotize Research and Development corp. 143
Not applicableStudy completedNCT04657445
What this trial is testing

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

Who this might be right for
Olfactory and Taste Dysfunction in SARS-CoV2 Infection
University Hospital, Ioannina 100
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Testing effectiveness (Phase 2)Study completedNCT04524663
What this trial is testing

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients

Who this might be right for
Covid19
Stanford University 49
Large-scale testing (Phase 3)UnknownNCT05758519
What this trial is testing

Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Qilu Pharmaceutical Co., Ltd. 1,220
Testing effectiveness (Phase 2)Study completedNCT05752175
What this trial is testing

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

Who this might be right for
COVID-19 Infection
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. 80
Large-scale testing (Phase 3)Ended earlyNCT04581915
What this trial is testing

PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19

Who this might be right for
Covid19
Wits Health Consortium (Pty) Ltd 74
Testing effectiveness (Phase 2)Study completedNCT04709835
What this trial is testing

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

Who this might be right for
COVID-19
Hoffmann-La Roche 104
Testing effectiveness (Phase 2)Ended earlyNCT04884295
What this trial is testing

Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19

Who this might be right for
Covid19
ExeVir Bio BV 27
Not applicableUnknownNCT05366244
What this trial is testing

An Observational Study in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shanghai Pudong Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04707664
What this trial is testing

Sargramostim Use in COVID-19 to Recover Patient Health

Who this might be right for
Covid19SARS-CoV Infection
Partner Therapeutics, Inc. 600
Not applicableStudy completedNCT04716647
What this trial is testing

Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research

Who this might be right for
Covid19
Aarogyam UK 28
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Large-scale testing (Phase 3)Ended earlyNCT05541510
What this trial is testing

Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Advagene Biopharma Co. Ltd. 180
Testing effectiveness (Phase 2)UnknownNCT05733780
What this trial is testing

To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M

Who this might be right for
COVID-19SARS CoV 2 Infection
Bioxytran Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07157007
What this trial is testing

Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID - 19
Traws Pharma, Inc. 90
Testing effectiveness (Phase 2)WithdrawnNCT04290858
What this trial is testing

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection

Who this might be right for
Coronavirus InfectionsPneumonia, ViralDyspnea
Xijing Hospital
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation